Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...
Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to InvestingPro data ...
Pinterest (NYSE:PINS – Free Report) had its target price upped by Cantor Fitzgerald from $36.00 to $48.00 in a research note ...
It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...
Cantor Fitzgerald started coverage on shares of Science Applications International (NYSE:SAIC – Free Report) in a research ...
A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...
周一,在一起潜在新闻泄露事件后,Cantor Fitzgerald重申了对ORIC Pharmaceuticals (NASDAQ: ORIC ...
周一,Cantor Fitzgerald重申了对Nova Measuring Instruments (NASDAQ: NVMI ...
The Cantor Fitzgerald chair was grilled about prior bullish statements made about Tether during a recent Senate hearing.
Cantor Fitzgerald analyst Colin Canfield initiated coverage of Amentum (AMTM) with a Neutral rating and $25 price target Maximize Your ...